Analystreport

Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target raised by analysts at Royal Bank Of Canada from $117.00 to $120.00.

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations